Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
157 | Drugs in Context | journal | 0.101 Q4 | 36 | 0 | 79 | 0 | 1 | 62 | 0.00 | 0.00 | |
156 | Methods in Pharmacology and Toxicology | book series | 0.102 Q4 | 14 | 0 | 22 | 0 | 1 | 21 | 0.05 | 0.00 | |
155 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.104 Q4 | 29 | 5 | 9 | 374 | 1 | 3 | 0.11 | 74.80 | |
154 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.107 Q4 | 16 | 51 | 57 | 2510 | 3 | 57 | 0.05 | 49.22 | |
153 | Chinese Journal of Cancer Biotherapy | journal | 0.109 Q4 | 5 | 131 | 129 | 2871 | 9 | 126 | 0.07 | 21.92 | |
152 | Virologica Sinica | journal | 0.130 Q4 | 47 | 57 | 250 | 2412 | 31 | 248 | 0.17 | 42.32 | |
151 | Biomolecules and Therapeutics | journal | 0.131 Q4 | 56 | 61 | 65 | 2033 | 18 | 65 | 0.28 | 33.33 | |
150 | Molecular Medicine Reports | journal | 0.138 Q4 | 86 | 158 | 141 | 4463 | 32 | 141 | 0.23 | 28.25 | |
149 | Biomarker Insights | journal | 0.139 Q4 | 40 | 17 | 46 | 910 | 15 | 45 | 0.33 | 53.53 | |
148 | Journal of Biological Sciences (discontinued) | journal | 0.143 Q4 | 38 | 143 | 689 | 3965 | 184 | 689 | 0.26 | 27.73 | |
147 | Journal of Stem Cells | journal | 0.145 Q4 | 21 | 20 | 61 | 1079 | 18 | 60 | 0.26 | 53.95 | |
146 | Expert Opinion on Medical Diagnostics | journal | 0.155 Q4 | 28 | 58 | 158 | 5378 | 49 | 157 | 0.31 | 92.72 | |
145 | Gene Therapy and Regulation | journal | 0.158 Q4 | 7 | 6 | 6 | 440 | 3 | 5 | 0.50 | 73.33 | |
144 | Pteridines | journal | 0.158 Q4 | 19 | 12 | 48 | 272 | 22 | 45 | 0.37 | 22.67 | |
143 | Future Cardiology | journal | 0.163 Q4 | 43 | 62 | 200 | 3249 | 44 | 170 | 0.26 | 52.40 | |
142 | Current Cancer Therapy Reviews | journal | 0.173 Q4 | 17 | 32 | 100 | 3033 | 29 | 96 | 0.22 | 94.78 | |
141 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.182 Q4 | 40 | 6 | 18 | 0 | 13 | 18 | 0.00 | 0.00 | |
140 | Gene Therapy and Molecular Biology | journal | 0.193 Q4 | 18 | 30 | 100 | 1890 | 56 | 100 | 0.59 | 63.00 | |
139 | Current Enzyme Inhibition | journal | 0.205 Q4 | 19 | 20 | 74 | 2319 | 44 | 74 | 0.69 | 115.95 | |
138 | Turkish Journal of Pharmaceutical Sciences | journal | 0.209 Q4 | 22 | 22 | 49 | 522 | 12 | 49 | 0.12 | 23.73 | |
137 | Current Pharmacogenomics and Personalized Medicine | journal | 0.213 Q4 | 20 | 27 | 26 | 2321 | 16 | 26 | 0.62 | 85.96 | |
136 | Personalized Medicine | journal | 0.222 Q4 | 36 | 69 | 173 | 2470 | 107 | 146 | 0.67 | 35.80 | |
135 | Frontiers in Medicinal Chemistry | book series | 0.226 Q4 | 7 | 29 | 27 | 4600 | 13 | 26 | 0.00 | 158.62 | |
134 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.241 Q4 | 39 | 34 | 78 | 3498 | 51 | 78 | 0.66 | 102.88 | |
133 | Journal of Cardiovascular Translational Research | journal | 0.251 Q4 | 60 | 68 | 62 | 2852 | 18 | 55 | 0.29 | 41.94 | |
132 | Yaoxue Xuebao | journal | 0.254 Q4 | 36 | 244 | 688 | 4732 | 389 | 688 | 0.58 | 19.39 | |
131 | Drug Discovery Today: Disease Models | journal | 0.264 Q4 | 33 | 22 | 137 | 950 | 66 | 121 | 0.38 | 43.18 | |
130 | Drug Discovery Today: Technologies | journal | 0.264 Q4 | 62 | 6 | 103 | 222 | 94 | 93 | 0.23 | 37.00 | |
129 | MCB Molecular and Cellular Biomechanics | journal | 0.273 Q4 | 31 | 16 | 105 | 986 | 76 | 105 | 1.23 | 61.63 | |
128 | Clinical Proteomics | journal | 0.276 Q4 | 42 | 17 | 33 | 630 | 19 | 30 | 0.50 | 37.06 | |
127 | Letters in Drug Design and Discovery | journal | 0.281 Q4 | 37 | 98 | 299 | 2524 | 221 | 299 | 0.82 | 25.76 | |
126 | Journal of Asian Natural Products Research | journal | 0.289 Q4 | 51 | 162 | 444 | 2375 | 284 | 444 | 0.60 | 14.66 | |
125 | Drug Discovery Today: Therapeutic Strategies | journal | 0.300 Q4 | 31 | 22 | 165 | 901 | 124 | 150 | 0.46 | 40.95 | |
124 | Pharmaceutical Biology | journal | 0.328 Q4 | 88 | 188 | 370 | 5474 | 379 | 369 | 0.88 | 29.12 | |
123 | Frontiers in Drug Design and Discovery | book series | 0.330 Q3 | 9 | 18 | 41 | 2204 | 31 | 39 | 1.09 | 122.44 | |
122 | Current Pharmaceutical Analysis | journal | 0.382 Q3 | 27 | 36 | 87 | 3007 | 106 | 87 | 1.04 | 83.53 | |
121 | BioFactors | journal | 0.389 Q3 | 113 | 63 | 236 | 4648 | 337 | 231 | 1.07 | 73.78 | |
120 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.398 Q3 | 53 | 80 | 560 | 2441 | 471 | 560 | 0.80 | 30.51 | |
119 | Drug Discovery Today: Disease Mechanisms | journal | 0.400 Q3 | 28 | 9 | 154 | 431 | 114 | 140 | 0.89 | 47.89 | |
118 | Archives of Pharmacal Research | journal | 0.409 Q3 | 105 | 232 | 659 | 6581 | 912 | 659 | 1.35 | 28.37 | |
117 | International Journal of Peptide Research and Therapeutics | journal | 0.423 Q3 | 45 | 34 | 148 | 1099 | 155 | 146 | 0.99 | 32.32 | |
116 | Current Computer-Aided Drug Design | journal | 0.428 Q3 | 32 | 21 | 82 | 2108 | 135 | 76 | 1.78 | 100.38 | |
115 | Methods in molecular medicine | book series | 0.430 Q3 | 59 | 0 | 478 | 0 | 467 | 476 | 0.96 | 0.00 | |
114 | Current Molecular Pharmacology | journal | 0.438 Q3 | 49 | 27 | 23 | 3594 | 29 | 23 | 1.26 | 133.11 | |
113 | Molecular Cytogenetics | journal | 0.455 Q3 | 38 | 25 | 2 | 720 | 2 | 2 | 1.00 | 28.80 | |
112 | Journal of Trace Elements in Medicine and Biology | journal | 0.488 Q3 | 92 | 39 | 128 | 1461 | 267 | 123 | 1.84 | 37.46 | |
111 | SAR and QSAR in Environmental Research | journal | 0.523 Q3 | 54 | 38 | 131 | 1604 | 246 | 128 | 1.70 | 42.21 | |
110 | Molecules | journal | 0.528 Q3 | 227 | 406 | 571 | 15748 | 1100 | 563 | 1.96 | 38.79 | |
109 | Biotechnology and Applied Biochemistry | journal | 0.564 Q3 | 81 | 88 | 205 | 3622 | 424 | 204 | 2.01 | 41.16 | |
108 | BMC Chemical Biology | journal | 0.634 Q3 | 21 | 7 | 8 | 330 | 15 | 8 | 1.80 | 47.14 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®